CID 288691

Nsc150011

Structural Information

Molecular Formula
C20H16N2
SMILES
C1CCC2=C(C1)N=C3C4=CC=CC=C4C5=CC=CC=C5C3=N2
InChI
InChI=1S/C20H16N2/c1-3-9-15-13(7-1)14-8-2-4-10-16(14)20-19(15)21-17-11-5-6-12-18(17)22-20/h1-4,7-10H,5-6,11-12H2
InChIKey
MMPFZWXSTCVPMZ-UHFFFAOYSA-N
Compound name
10,11,12,13-tetrahydrophenanthro[9,10-b]quinoxaline
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

4
Patents

284.13135 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 285.13863 164.2
[M+Na]+ 307.12057 173.5
[M-H]- 283.12407 168.1
[M+NH4]+ 302.16517 180.7
[M+K]+ 323.09451 165.5
[M+H-H2O]+ 267.12861 153.1
[M+HCOO]- 329.12955 179.4
[M+CH3COO]- 343.14520 174.7
[M+Na-2H]- 305.10602 174.9
[M]+ 284.13080 162.7
[M]- 284.13190 162.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe